Alfuzosin: A Review of the Therapeutic Use of the Prolonged-Release Formulation Given Once Daily in the Management of Benign Prostatic Hyperplasia

By McKeage K.   Plosker G.L.  

Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. : 633-653

Adis International

Access to resources Recommend Favorite

Alfuzosin: an α₁-receptor blocker for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

By Elhilali Mostafa M  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 583-596

Informa Healthcare

Access to resources Recommend Favorite

Doxazosin and alfuzosin have similar efficacy in improving obstructive symptoms associated with benign prostatic hyperplasia

By  

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Efficacy of Low-Dose Tamsulosin on Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Nonblind Multicentre Korean Study

By Choal Hee Park  

Clinical Drug Investigation, Vol. 24, Iss. 1, 2004-01 ,pp. : 41-47

Adis International

Access to resources Recommend Favorite

Silodosin: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia

By Osman Nadir I   Chapple Christopher R   Cruz Francisco   Desgrandchamps François   Llorente Carlos   Montorsi Francesco  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2085-2096

Informa Healthcare

Access to resources Recommend Favorite